Division of Gastroenterology Hepatology and Nutrition

New target for colorectal cancer

Vanderbilt investigators have discovered that activated epidermal growth factor receptor may be a target for therapies to prevent colorectal cancer development.

New target for chronic infection

An enzyme in macrophage immune cells may be a good target for treating chronic infections, Vanderbilt researchers have discovered.

Digestive Disease Research Center lands major grant

The Vanderbilt Digestive Disease Research Center (VDDRC) celebrates its 15th anniversary this year with a third consecutive five-year renewal of its federal research grant.

firefighters battle a wildfire

EGF receptor found to regulate macrophage inflammation in gut

Researchers at Vanderbilt University School of Medicine have uncovered a link between epidermal growth factor receptor (EGFR) signaling and the inflammatory response to bacterial infection in the gastrointestinal tract.

molecules stuck together

‘Young Scientist’ showcases high schoolers’ research at Vanderbilt

High school students performing advanced research at Vanderbilt have the opportunity to share their findings with the scientific community through a journal of their own.

Williams to lead physician-scientist training program 

Christopher Williams, M.D., Ph.D., associate professor of Medicine and Cancer Biology, was recently named associate dean for Vanderbilt University School of Medicine’s Physician-Scientist Education and Training Program (PSTP) and director of the Medical Science Training Program (MSTP).

1 3 4 5 6 7